Αρχική World News Biomedical Engineering Student Invents Device for At-Home Breast Cancer Screening

Biomedical Engineering Student Invents Device for At-Home Breast Cancer Screening

Judit Giró Benet, who was a biomedical engineering student at the University of Barcelona at the time, first got the idea for the Blue Box when she found out that nearly 40 percent of women skip their routine breast cancer screenings. About one-third of cancers are detected too late to be survived, so Judit knew that it was important to encourage people to get screened.

“The way I got inspired to start developing The Blue Box is [that] I heard there was a dog that could smell cancer and bark,” says Judit. “I really loved this approach because I always think that, to create great design, you should observe biology and then learn from that. So I thought, ‘Yeah, nature has a way to diagnose cancer already. Let’s try to copy it.’”

Photo: Instagram/thebluebox.ai

Judit was also disturbed by the fact that approximately 94 percent of breast cancers detected on mammograms turn out to be false alarms, as reported by the Catalan Department of Health in Spain. So Judit took her knowledge of nature and set to work creating a device that would increase people’s access to breast cancer screening and hopefully be more effective than traditional mammograms.

In 2017, during her final year at the university, Judit developed a prototype of the Blue Box as part of her bachelor thesis. She experimented with different sensors to detect breast cancer biomarkers in urine samples from a hospital. Her goal was to prove that “the metabolite analysis performed by The Blue Box is sufficiently significant to discriminate control from breast cancer class.”

Photo: Instagram/thebluebox.ai

Article continues below

Our Featured Programs

See how we’re making a difference for People, Pets, and the Planet and how you can get involved!

“In the design process, there [were] some challenges,” Judit recalls. “There [are] some things…in the papers that have been published. You have to read those…and then you have to [figure out] after learning all of these [things] what hypothesis you have.”

Judit spent more time on her invention after graduation and then decided to dedicate her entire time as a master’s student studying embedded and cyber-physical systems at the University of California Irvine on developing a second prototype of the Blue Box. Another student with a background in computer science collaborated with her on the project.

“The reason I did this for my master’s is because I thought, ‘Okay, The Blue Box works, but it works for advanced breast cancer.’” Judit says. “So, for late-stage breast cancer, I want to optimize it. I want to make it better. How can I learn what I’m lacking?”

Photo: Instagram/thebluebox.ai

As the invention exists now, it contains six chemical sensors that react to different breast cancer biomarkers within urine samples. The device then sends a signal to a cloud, where an AI-powered algorithm generates a diagnosis and sends the results to the user’s phone. Judit says the box correctly classifies samples 95 percent of the time.

“I want The Blue Box to be a safe space for a community that unites women [who] have decided to take care of their own health,” she says. “Women have to prevent breast cancer, taking an active role together with their doctors.”

Photo: Instagram/thebluebox.ai

Judit was awarded the prestigious James Dyson Award — an honor given to students who tackle the world’s most pressing problems. She says the award increased her social media presence and got the word out about the Blue Box to women who might be able to use it. Currently, Judit is seeking funding so she can secure a patent and continue testing the device. After that, she hopes to get a government grant and FDA approval so the Blue Box can go on the market.

Photo: Instagram/thebluebox.ai

“There is a need for diseases or medical conditions that affect mostly women to be treated, to be investigated and to be solved,” says Judit. “And this is one of the goals of The Blue Box.”

We can’t wait to see this product hit the market. It could totally revolutionize the accessibility of breast cancer screening and make the process more comfortable for many women. Check out the video below to learn more.

Provide Mammograms

Support those fighting Breast Cancer at The Breast Cancer Site for free!

Whizzco Source


Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Despite Proven Safety of HPV Vaccines, More Parents Have Concerns

October 22, 2021, by NCI Staff Credit: National Cancer Institute Despite more than 15 years of consistent evidence that HPV vaccines are safe and effective, a...

FDA Approves Atezolizumab as Adjuvant Treatment for Non-Small Cell Lung Cancer

On 15 October 2021, the US Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for adjuvant treatment following resection and platinum-based chemotherapy...

Breast Cancer Survivor Uses Comedy to Spread Awareness and Address Disparities

Suzette Simon lost her mother to breast cancer. In 2020, she learned that she had the disease, as well. Realizing how much harder breast...

Why Wearing Comfortable Clothes During Cancer Treatment Matters

Voices on Cancer is an award-winning Cancer.Net Blog series where advocates share their stories and the lessons they have learned about being a cancer advocate. Cindy Trice is...

Breast cancer surgery: ‘I’m proud of the tattoos inked across my chest’

Wendy had a double mastectomy in 2017 and remained flat. “When the consultant told me, I remember crying and saying that I have 2 young...

EMA Recommends Granting a Marketing Authorisation for Zanubrutinib for the Treatment of Waldenström’s Macroglobulinaemia

On 16 September 2021, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of...